Curi Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-64
Closed -$10K – 586
2022
Q2
$10K Hold
64
– – ﹤0.01% 376
2022
Q1
$12K Hold
64
– – ﹤0.01% 345
2021
Q4
$16K Buy
+64
New +$17.2K ﹤0.01% 271
2021
Q1
– Sell
-64
Closed -$12K – 402
2020
Q4
$12K Buy
+64
New +$11.6K 0.01% 231

Other funds holding RGEN

Curi Wealth Management's RGEN Position: Q3 2022 in Review

Curi Wealth Management sold out of Repligen (RGEN) in Q3 2022, closing a stake of 64 shares — an estimated $10K sold.

Curi Wealth Management first reported a position in RGEN in Q4 2020 and held it in 4 quarters. The position peaked at $16K in Q4 2021. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.

  • Curi Wealth Management reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
  • Curi Wealth Management sold 64 Repligen shares in Q3 2022, an estimated $10K.
  • Curi Wealth Management first reported a position in Repligen in Q4 2020 and held it in 4 quarters.
  • Curi Wealth Management's Repligen position peaked at $16K in Q4 2021.
  • 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.

Based on Curi Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.